At Issue: Should Medicare Be Allowed to Negotiate Drug Prices?
Should Medicare Be Allowed to Negotiate Drug Prices?
The Case for Constructive Ambiguity in a Regulated System: Canadian Banks and the
Natural Assets: Democratizing Environmental Ownership